Pinned
Many AI tools impacting patient care may be operating outside of FDA oversight.
To change that, MIT researchers recommend increased public disclosure, structured dialogue between industry & regulators, & updated FDA guidance: bit.ly/4fDjIz5
![]() |
VOOZH | about |